A Safety and Efficacy Study of Bacopa Monnieri and Nardostachys Jatamansi to Treat Schizophrenia

• Status: Completed
• Trial end date: 2007-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether a herbal combination of water based extracts of Bacopa monnieri(BM) and Nardostachys jatamansi(NJ) is effective in the treatment of Schizophrenia.

The working hypothesis for this study is that a herbal combination of BM and NJ will be as effective as modern anti-psychotic drugs, in the treatment of Schizophrenia, and will be safe for long term use.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Q.Mundewadi Ayurvedic Research & Charitable Trust
• Collaborator: Stanley Medical Research Institute
• Treatments: Olanzapine

Criteria

Inclusion Criteria:

• Any sex

• Age 18 - 60 years

• History suggestive of Schizophrenia using the DSM-IV-TR diagnostic criteria.

• Presence of a caretaker/legal guardian who would take the responsibility of giving regular medication and bringing the patient for regular follow-ups.

Exclusion Criteria:

• Age< 18 or > 60 years

• Known history of drug addiction

• Known medical history which may cause similar symptoms e.g. Schizoaffective /Mood Disorders, Pervasive Developmental Disorder

• History of severe or repeated episodes of violence.

• History of any other concurrent illness which could interfere in the treatment and assessment of the subject.